Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Tauns Laboratories, Inc. ( (JP:197A) ).
Tauns Laboratories, Inc. reported a 7.6% increase in net sales for the nine months ending March 31, 2025, with notable rises in operating and net income. The company forecasts continued growth in FY2025, with a slight increase in dividends, reflecting a stable financial position and positive outlook in the healthcare market.
More about Tauns Laboratories, Inc.
Tauns Laboratories, Inc. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical and healthcare industry. It focuses on developing and providing diagnostic and therapeutic products, catering to a wide range of healthcare needs.
Average Trading Volume: 612,640
Technical Sentiment Signal: Strong Sell
See more data about 197A stock on TipRanks’ Stock Analysis page.